Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Antiviral Therapy|June 25, 2013
Bioinformatics methods for the analysis of hepatitis virusesFrancesco Moriconi, Michael R Beard, Lilly Kw Yuen
Journal of Virological Methods|February 9, 2013
Optimization of in vitro HBV replication and HBsAg production in HuH7 cell lineDaniela Cavallone, Francesco Moriconi, Piero Colombatto, et al.
The Journal of Infection|June 26, 2013
Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis BNicola Coppola, Gilda Tonziello, Piero Colombatto, et al.
Alimentary Pharmacology & Therapeutics|May 12, 2020
Do the circulating Pre-S/S quasispecies influence hepatitis B virus surface antigen levels in the HBeAg negative phase of HBV infection?Daniela Cavallone, Gabriele Ricco, Filippo Oliveri, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 15, 2007
Viral load 1 week after liver transplantation, donor age and rejections correlate with the outcome of recurrent hepatitis CPietro Ciccorossi, Anna Maria Maina, Filippo Oliveri, et al.
Gastroenterology|May 11, 2010
Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriersMaurizia Rossana Brunetto, Filippo Oliveri, Piero Colombatto, et al.
Plos One|October 29, 2014
A serum microRNA signature is associated with the immune control of chronic hepatitis B virus infectionMaurizia Rossana Brunetto, Daniela Cavallone, Filippo Oliveri, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 16, 2017
Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearanceFilippo Oliveri, Lidia Surace, Daniela Cavallone, et al.
Pageof 2